Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2191]

Rewriting the code of life: CRISPR-Cas9 genome editing

Prof Jennifer Doudna - University of Berkeley, Berkeley, USA

Rewriting the code of life: CRISPR-Cas9 genome editing ( Prof Jennifer Doudna - University of Berkeley, Berkeley, USA )

Direct targeting of STAT3 alone and in combination with immune checkpoint...

Dr David Tweardy - The University of Texas MD Anderson Cancer Center, Houston...

Direct targeting of STAT3 alone and in combination with immune checkpoint inhibitors to treat solid tumours ( Dr David Tweardy - The University of Texas MD Anderson Cancer Center, Houston, USA )

Optimising patient enrolment and efficacy of precision oncology clinical trials

Prof Apostolia-Maria Tsimberidou - The University of Texas MD Anderson Cancer...

Optimising patient enrolment and efficacy of precision oncology clinical trials ( Prof Apostolia-Maria Tsimberidou - The University of Texas MD Anderson Cancer Center, Houston, USA )

Innovative algorithms and IT platform to support clinical trials

Dr Eitan Rubin - Ben-Gurion University of the Negev, Beersheeba, Israel

Innovative algorithms and IT platform to support clinical trials ( Dr Eitan Rubin - Ben-Gurion University of the Negev, Beersheeba, Israel )

Comment: POLO III trial for metastatic pancreatic cancer

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

Comment: POLO III trial for metastatic pancreatic cancer ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )

Getting high level care to low and middle income countries

Dr Eduardo Cazap, Dr Clifford Hudis

Getting high level care to low and middle income countries ( Dr Eduardo Cazap, Dr Clifford Hudis )

Tackling the increase in cancer cases worldwide

Dr Eduardo Cazap and Prof Tezer Kutluk

Tackling the increase in cancer cases worldwide ( Dr Eduardo Cazap and Prof Tezer Kutluk )

CD-19 mutation frequency after blinatumomab treatment is lower than after CAR T...

Dr Michaela Kotrova - Universitätsklinikum Schleswig-Holstein, Kiel, Germany

CD-19 mutation frequency after blinatumomab treatment is lower than after CAR T-cell therapy ( Dr Michaela Kotrova - Universitätsklinikum Schleswig-Holstein, Kiel, Germany )

Multiple myeloma science from EHA 2019

Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France

Multiple myeloma science from EHA 2019 ( Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France )

Controlling CRS-related coagulopathy improves the safety of CAR T-cell therapy...

Dr Heng Mei - Huazhong University of Science and Technology, Wuhan, China

Controlling CRS-related coagulopathy improves the safety of CAR T-cell therapy for MM ( Dr Heng Mei - Huazhong University of Science and Technology, Wuhan, China )

Chemoimmunotherapy or BTK inhibition for patients with CLL

Dr Othman Al-Sawaf - University of Cologne, Cologne, Germany

Chemoimmunotherapy or BTK inhibition for patients with CLL ( Dr Othman Al-Sawaf - University of Cologne, Cologne, Germany )

Using bioinformatics and genomics to treat AML

Prof Torsten Haferlach - MLL Münchner Leukämielabor GmbH, Munich, Germany

Using bioinformatics and genomics to treat AML ( Prof Torsten Haferlach - MLL Münchner Leukämielabor GmbH, Munich, Germany )

More from ecancer